...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of cardiac failure >Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure.
【24h】

Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure.

机译：MDASI-HF的心理测验：用于癌症和并发心力衰竭患者的症状评估工具。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: The debilitating symptoms of cancer and heart failure (HF) can adversely affect the patient's quality of life. This study evaluated the psychometric properties of the MD Anderson Symptom Inventory--Heart Failure (MDASI-HF), a 27-item self-report assessment instrument for patients with cancer and concurrent HF. METHODS AND RESULTS: Psychometric testing used data from 156 patients (age 63.3 +/- 13.2 years, 56% male) with a diagnosis of cancer and HF receiving care in a major cancer center. Reliability of the MDASI-HF for the 13 symptoms (alpha = 0.89), 8 HF-specific items (alpha = 0.83), and interference items (alpha = 0.92) was high. Criterion-related validity with the Eastern Cooperative Oncology Group performance scale (r = 0.63) and the New York Heart Association classification (r = 0.65) were statistically significant, P = .01. Construct validity supported two constructs for the additional HF specific items: covert HF factor and overt HF factor. CONCLUSION: The MDASI-HF is a valid and reliable instrument for symptom assessment in patients with cancer and HF. This instrument can be used to identify symptom occurrence and enhance the provider's understanding of the prevalence and severity of symptoms from the patient's perspective.
机译：背景：癌症和心力衰竭（HF）的虚弱症状可能会对患者的生活质量产生不利影响。这项研究评估了MD安德森症状量表-心力衰竭（MDASI-HF）的心理测量特性，这是一项针对患有癌症和并发HF的患者的27项自我报告评估工具。方法和结果：心理测试使用了来自156名在主要癌症中心诊断为癌症和心衰的患者（年龄63.3 +/- 13.2岁，男性56％）的数据。 MDASI-HF对13种症状（alpha = 0.89），8种HF特定项目（alpha = 0.83）和干扰项目（alpha = 0.92）的可靠性很高。与东部合作肿瘤小组绩效量表（r = 0.63）和纽约心脏协会分类（r = 0.65）的标准相关的有效性具有统计学意义，P = 0.01。建构效度支持了针对其他HF特定项目的两种建构：秘密HF因子和明显的HF因子。结论：MDASI-HF是用于癌症和HF患者症状评估的有效且可靠的工具。该仪器可用于识别症状的发生，并增强提供者从患者的角度对症状的普遍性和严重性的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号